NCT00402766 - Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Mesothelioma

Interventions

DRUG

Cisplatin

Starting Dose: 60 mg/m\^2 by vein, Over 2 Hours

DRUG

Imatinib Mesylate

Starting Dose: 300 mg PO Daily

DRUG

Pemetrexed

Starting Dose: 500 mg/m\^2 by vein, Over 40 Minutes

DRUG

Dexamethasone

20 mg by vein given prior to Pemetrexed therapy and 4 mg given orally on Day 2 of each cycle.

Trial Locations (1)

University of Texas MD Anderson Cancer Center, Houston